Testing effectiveness (Phase 2)Study completedNCT01075100What this trial is testingIxabepilone + Carboplatin Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer US Oncology Research 103
Testing effectiveness (Phase 2)WithdrawnNCT03872505What this trial is testingPre-operAtive Non-Anthracycline Chemotherapy, Durvalumab +/- RAdiation Therapy in Triple Negative Breast CancerWho this might be right forBreast CancerTriple Negative Breast Cancer Cedars-Sinai Medical Center
Not applicableEnded earlyNCT02454777What this trial is testingHigh-Intensity Interval Training for Stage I-III Breast Cancer PatientsWho this might be right forStage IA Breast CancerStage IB Breast CancerStage IIA Breast Cancer+4 more University of Southern California 31
Not applicableUnknownNCT04769050What this trial is testingDynamic Observational Study With PET of 68Ga-HER2-affibody in Anti-HER2 TreatmentWho this might be right forBreast Cancer Fudan University 50
Large-scale testing (Phase 3)Study completedNCT00005590What this trial is testingLevofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or LymphomaWho this might be right forBrain and Central Nervous System TumorsBreast CancerExtragonadal Germ Cell Tumor+7 more Cancer Research Campaign Clinical Trials Centre
Testing effectiveness (Phase 2)UnknownNCT00497458What this trial is testingAndrogen Therapy for Breast Cancer Patients With Aromatase Inhibitor Induced Side-EffectsWho this might be right forBreast CancerArthralgiaOsteoporosis Havah Therapeutics Pty Ltd 90
Large-scale testing (Phase 3)UnknownNCT00301925What this trial is testingCombination Chemotherapy in Treating Patients With Early Stage Breast Cancer That Has Been Removed By SurgeryWho this might be right forBreast Cancer Institute of Cancer Research, United Kingdom 4,400
Early research (Phase 1)Ended earlyNCT01238133What this trial is testingGamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097, Paclitaxel, and Carboplatin Before Surgery in Treating Patients With Stage II or Stage III Triple-Negative Breast CancerWho this might be right forEstrogen Receptor NegativeHER2/Neu NegativeProgesterone Receptor Negative+6 more National Cancer Institute (NCI) 14
Testing effectiveness (Phase 2)Ended earlyNCT00597597What this trial is testingPhase II Open-Label Trial of Tarceva in Women With Metastatic, Hormone- and HER2-Negative Breast CancerWho this might be right forMetastatic Breast Cancer Rush University Medical Center 11
Testing effectiveness (Phase 2)Looking for participantsNCT06617455What this trial is testingFezolinetant for the Improvement of Vasomotor Symptoms in Breast Cancer Patients Taking Endocrine Therapy, VENT TrialWho this might be right forAnatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+2 more University of Michigan Rogel Cancer Center 36
Not applicableEnded earlyNCT01722890What this trial is testingCharactHer. ICORG 12-09, V3Who this might be right forHER2-positive Breast CancerTNM Stage II-IV Breast Cancer Cancer Trials Ireland 130
Testing effectiveness (Phase 2)Study completedNCT00369655What this trial is testingVEGF Trap in Treating Patients With Metastatic Breast CancerWho this might be right forMetastatic Breast CancerRecurrent Breast CancerStage IV Breast Cancer National Cancer Institute (NCI) 21
Testing effectiveness (Phase 2)Study completedNCT03822468What this trial is testingStudy of 2 Ribociclib Doses in Combination With Aromatase Inhibitors in Women With HR+, HER2- Advanced Breast CancerWho this might be right forBreast Cancer Novartis Pharmaceuticals 376
Testing effectiveness (Phase 2)Study completedNCT01271725What this trial is testingLUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment FailuresWho this might be right forBreast Neoplasms Boehringer Ingelheim 74
Testing effectiveness (Phase 2)Study completedNCT00077376What this trial is testingTrastuzumab, Ixabepilone, and Carboplatin in Treating Patients With HER2/Neu-Positive Metastatic Breast CancerWho this might be right forHER2-positive Breast CancerMale Breast CancerRecurrent Breast Cancer+1 more National Cancer Institute (NCI) 61
Testing effectiveness (Phase 2)WithdrawnNCT00397501What this trial is testingBBBD Followed By Methotrexate and Carboplatin With or Without Trastuzumab in Treating Women With Breast Cancer That Has Spread to the BrainWho this might be right forBrain and Central Nervous System TumorsBreast CancerCognitive/Functional Effects+2 more OHSU Knight Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT00416715What this trial is testingVitamin D Deficiency, Muscle Pain, Joint Pain, and Joint Stiffness in Postmenopausal Women Receiving Letrozole For Stage I-III Breast CancerWho this might be right forArthralgiaMusculoskeletal ComplicationsPain+6 more University of Washington 100
Testing effectiveness (Phase 2)Study completedNCT00193076What this trial is testingCombination Gemcitabine, Carboplatin With or Without Trastuzumab in Patients With Metastatic Breast CancerWho this might be right forBreast Cancer SCRI Development Innovations, LLC 96
Testing effectiveness (Phase 2)Study completedNCT00020332What this trial is testingDocetaxel and Flavopiridol in Treating Patients With Locally Advanced or Metastatic Breast CancerWho this might be right forBreast Cancer National Cancer Institute (NCI)
Large-scale testing (Phase 3)Looking for participantsNCT06891833What this trial is testingBL-M07D1 With or Without Pertuzumab Versus Taxane + Trastuzumab and Pertuzumab in Neoadjuvant Therapy for HER2-Positive Breast CancerWho this might be right forHER2-positive Breast Cancer Sichuan Baili Pharmaceutical Co., Ltd. 120